#U.S. Dialysis Centers Market 2030

[neha24blog]

U.S. Dialysis Centers Market Segmented On The Basis Of Modality, Dialysis Type, Facility Type, Region And Forecast 2030: Grand View Research Inc.

U.S. Dialysis Centers Market Segmented On The Basis Of Modality, Dialysis Type, Facility Type, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 26 Dec 2022: The Report U.S. Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-center, In-home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, By Region, And Segment Forecasts, 2023 – 2030 The U.S. dialysis centers market size is expected to reach USD 40.4 billion by 2030, based on a new report by Grand View Research,…

[market-insider]

Florida's Dialysis Centers Market Trends and Forecast: Charting Success

The Florida dialysis centers market size is expected to reach USD 1.3 billion by 2030. The growth is attributed to increasing R&D investments by medical device companies and the increasing prevalence of CKD. According to the American Kidney Fund, around 48,215 individuals in the state are suffering from ESRD. Of these, 34,847 residents depend on dialysis to stay alive; the remaining 13,368 have undergone kidney transplants.

Gain deeper insights on the Carpet And Upholstery Cleaning Services market and receive your free copy with TOC now @: Florida Dialysis Centers Market Report

The rising demand for dialysis units across Florida is an important factor anticipated to boost the market growth over the forecast period. Thus, the introduction of new dialysis facilities in Florida is expected to fuel market growth. For instance, in January 2022, U.S. Renal Care announced the launch of four more facilities as part of the ongoing expansion of its in-center hemodialysis services in Southwest Florida. With the introduction of three additional clinics, U.S. Renal Care now has a total of seven clinics in the region.

The COVID-19 pandemic negatively impacted the Florida dialysis center market. Several cases of COVID-19 were causing complications such as kidney conditions, leading to shorter patient treatment times as well as a decline in staff & supply shortages that were impeding access to life-sustaining treatments. The impact of COVID-19 on people with kidney disorders led to the first drop in the number of patients on dialysis in the U.S. in the 50-year history of the Medicare ESRD Program.

[healthcare-market]

Unfractionated Heparin Market to Receive Overwhelming Hike in Revenues by 2027

Transparency Market Research (TMR) titled, “Unfractionated Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global Unfractionated Heparin Market was valued at US$ 1.0 Bn in 2018 and is projected to expand at a CAGR of 6.4% from 2019 to 2027.

Request a Sample of Unfractionated Heparin Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32198

Increasing number of surgical procedures to Drive Global Market

· Unfractionated heparin is a naturally occurring anticoagulant that is primarily in dialysis and heart lung machines to prevent blood clots as well as for the treatment of blood clotting disorder like deep venous thrombosis and pulmonary embolism.

· Due to its immediate onset of action, short half-life, simple laboratory monitoring, ability to get reversed (protamine), and low cost have led to its wide adoption.

· Increase in use of unfractionated heparin for the treatment of venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE) along with increasing number of surgical procedures are the major drivers for global unfractionated heparin market.

· Patent expiration for majority of unfractionated heparin have already created a huge latent opportunity for generic and biosimilars manufacturers in the forthcoming years.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32198

Porcine Segment to Lead Global Unfractionated Heparin Market

· Bovine sourced unfractionated heparin is banned in the U.S. and Europe region post-1990s due to the spread of bovine spongiform encephalopathy (BSE) disease in cattle. Recently (2014) the Center for Drug Evaluation and Research (CDER), U.S. proposed to re-introduce bovine sourced heparin due to shortage of porcine sourced unfractionated heparin.

Request for Analysis of COVID19 Impact on Unfractionated Heparin Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32198

Hospitals Segment to Dominate Global Unfractionated Heparin Market

· By distribution channel, hospital pharmacies segment dominate the market owing to increase in number of hospital surgeries and hospital stay. Rise in use of internet, and surge of e-commerce expected to boost the growth of online pharmacies segment in near future.

Enquiry before Buying Unfractionated Heparin Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=32198

Europe Dominated Global Unfractionated Heparin Market

· Europe dominated the global unfractionated heparin market is terms of revenue in 2019 and is expected to dominate the market during the forecast period. Europe is expected to grow at an impressive CAGR of 6.5% during the forecast period. Increase in number of research activities and rise in prevalence of diseases are expected boost the growth of the market. Major market share held by the region is attributable to ongoing research on unfractionated heparin for different indications and the growing pharmaceutical industry in Europe region.

· The unfractionated heparin market in Asia Pacific is projected to grow at a rapid pace during the forecast period. Increase in geriatric population, rise in prevalence of diseases that cause hearing loss, surge in research & development, extensive government initiatives in the health care sector, and increase in presence & investments by global players fuel the growth of the unfractionated heparin market in Asia Pacific.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/players-in-pressure-relief-devices-market-lean-on-launching-smart-therapeutic-beds-for-preventing-pressure-injuries-in-patients-market-valuation-to-reach-us-4-54-bn-by-2030--finds-tmr-301349292.html

https://www.prnewswire.com/news-releases/urgent-care-centers-market-valuation-to-reach-us-35-4-bn-by-2027-due-to-increased-access-to-healthcare-low-cost-of-treatment-finds-a-tmr-study-301355857.html

https://www.prnewswire.com/news-releases/rise-in-prevalence-of-dry-eye-disease-due-to-ageing-use-of-computers-to-drive-dry-eye-disease-treatment-market-says-tmr-301360562.html

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

[decisionforsight]

Global Dialysis Market

Global Dialysis Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

The global Dialysis market size was valued at USD 3.7 million in 2020 and is estimated to reach USD 5.5 million by 2030, growing at a CAGR of 4% during the forecast period.Dialysis is a medical-based treatment of eliminating waste products and excess fluid from the blood of the human body when the kidneys stop working properly. Dialysis performs the function of the kidneys, which involves diverting blood to a machine to be cleaned, using a special fluid called dialysate, which is a mixture of pure water and chemicals, to pull wastes out of blood without removing necessary fluids and electrolytes needed by the body. This helps to keep the patient's body in balance when the kidneys are not functioning. Healthy kidneys prevent extra water, waste, and other impurities from accumulating in our body, in case if kidneys fail to do so, dialysis comes into work. Kidneys help to control blood pressure and regulate the levels of chemical elements in the blood. When the kidneys can’t functions due to disease or injury, dialysis keeps the body as normally as possible. Without dialysis, salts and other waste products get accumulate in the blood which will poison the body, and damage other organs. The dialysis market is supported by innovative and advanced technology, where medical devices have helped many patients who have kidney failure issues. 

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020187

Market Dynamics and Factors:

The global dialysis market is growing rapidly, which is mainly driven by the increasing aging population and the rise in health issues like renal kidney diseases. An increase in the aging population, the rising predominance of chronic diseases and the high prevalence of kidney infections are key factors driving the growth of the global dialysis market. Favorable reimbursement policies and new technologies in dialysis products are positively impacting the market which will tend to grow the dialysis market in the future. Growth of the market is hampered by factors such as poor reimbursement schemes and processes, high risks and cautions. High treatment cost and strict regulations related to dialysis products are the major challenges which limit the patients from getting the treatment and slows down the market growth.

Market Segmentation:

Global Dialysis Market – By Procedure Type

Hemodialysis

Peritoneal Dialysis

Global Dialysis Market – By Product 

Equipment Consumables

Services

Global Dialysis Market – By Application 

Hospitals

Dialysis Centers

Others

Global Dialysis Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020187

Geographic Analysis:

The global dialysis market is expected to grow by approximately 4% CAGR by 2025. The market is dominated by North America due to advancements in technology, the presence of leading vendors like ( Fresenius Medical Care North America, DaVita Kidney Care, and U.S. Renal Care), an increase in regulatory reforms, and changes in reimbursement policies. Europe is followed by North America and has similar potential in growth and development. APAC is the most focused and fastest-growing region due to vast opportunities for vendors to establish their presence. The factors such as the presence of a large pool of chronic patients, increasing aging population, support from the government, and health & wellness programs are expected to boost the market growth.

Competitive Scenario:

The major key players operating in the dialysis industry include B. Braun, Toray, Baxter International, Kawasumi Laboratories, Asahi Kasei, JMS, Fresenius Medical Care, Nikkiso, Medtronic and Nipro. Baxter International is one of the leading players in the dialysis industry offering an extensive product and service portfolio.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020187 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Dialysis Market industry, although key threats, opportunities and disruptive technologies that could shape the Global Dialysis Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Dialysis Market most.

The data analysis present in the Global Dialysis Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Dialysis Market business.

The 2021 Annual Global Dialysis Market offers:

100+ charts exploring and analysing the Global Dialysis Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Dialysis Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020187 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[adwaitcoherent]

By 2026, U.S. Central Venous Catheter Market To Surpass US$ 1,332.2 Million - Coherent Market Insights

U.S. Central Venous Catheter Market To exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

Request for Sample PDF Copy:

https://www.coherentmarketinsights.com/insight/request-pdf/2610

Description:

Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

 The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

 Figure 1. U.S. Central Venous Catheter Market Value (US$ Mn), by Design, 2018

U.S. Central Venous Catheter | Coherent Market Insights

                                                                      Source: Coherent Market Insights Analysis (2019)

 Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

 Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

 According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

 According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

 Figure 2. U.S. Central Venous Catheter Market Share (%), by Design, 2018 and 2026

U.S. Central Venous Catheter | Coherent Market Insights

                                                                    Source: Coherent Market Insights Analysis (2018)

 Increasing collaboration strategies adopted by market players is expected to bolster growth of the U.S. central venous catheter market

 The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

 Key Players

 Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.

 Buy Report Here:

https://www.coherentmarketinsights.com/insight/buy-now/2610

Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave.  #3200  Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

[martynnx-blog]

Future of the U.S. Central Venous Catheter Market  Adds New Dimension to Innovations till 2026

Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2610

The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving the central venous catheter market growth. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received the U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2610

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

[healthcare00897]

U.S. Central Venous Catheter Market Business Segmentation by Revenue, Market Landscape, Present Scenario and Growth Prospects 2026

Central venous catheters consist of a long, thin tube that is inserted into a large vein to deliver medication, nutrition, intravenous fluids, and cancer medications. Different types of central venous catheters can be utilized by patients according to the duration of the treatment. These include, tunneled central venous catheters (CVC) and implanted ports for long term use, peripherally inserted central catheter (PICC) for intermediate term, and non-tunneled CVC for short term use. Central venous catheterization is used for chemotherapy administration, total parenteral nutrition, administration of intravenous fluids and blood, platelet transfusions, and other applications.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving the central venous catheter market growth. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received the U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2610

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Increasing collaboration strategies adopted by market players is expected to bolster growth of the U.S. central venous catheter market

The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

[decisionforsight]

Global Disposable Medical Supplies Market

Global Disposable Medical Supplies Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

The global disposable medical supplies market was valued at USD 64622.47 million in 2020, and is expected to reach USD 128315.24 million by 2030, registering a CAGR of 7.1% during the forecast period.Disposable medical supplies are medical consumables which are non-durable, that are usually disposable in nature. These supplies cannot survive repeated usage by more than one individual. Development of disposable supplies was aimed at reducing the infections in hospital settings such as bloodstream infections hospital-acquired pneumonia, urinary tract infections, and others. It is protective equipment used to protect healthcare workers against infections and diseases. It also prevent cross contamination between doctor and caregivers and doctor and patient during medical examination, surgical procedure and chemotherapy. It is an integral part of the infection control strategy and their uses regulated by FDA class I reserved medical device. The need for disposable medical supplies has witnessed reliable growth, as hospitals and outpatient facilities are implementing severe infection prevention safety measures to be at par with the standards. Growing rate of disease & disorders and rising aging population are the factors that drive the growth for disposable medical supplies market. 

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020322

Market Dynamics and Factors:

High necessity for disposable medical supplies and favorable government regulations for their mandated use drive the market. Growth will be driven by increasing volume of patient activity, aging populations, rising epidemiological trends, improvements in developing world healthcare systems, and the acceptance of stricter healthcare infection hindrance protocols throughout the world. However, the insufficient compensation scenario for these products and increase in environmental concerns due to the disposable of medical wastes are expected to restrict the market growth. For instance, according to WHO, about 16 billion injections are administered globally, thus increasing the amount of waste. The market driving by the growing volume of surgeries, growth in the frequency of chronic diseases and growing medical tourism in the region. Increasing number of surgeries will fuel the demand for surgical gowns, hand gloves, drapes, procedure kits and trays, and feeding tube will give a push to the disposable medical supplies market worldwide.  

Market Segmentation:

Global Disposable Medical Supplies Market – By Product Type

Diagnostic Supplies

Dialysis Consumables

Radiology Consumables

Infusion Products

Intubation & Ventilation Supplies

Hypodermic Products

Sterilization Consumables

Nonwoven Medical Supplies

Wound Care Consumables

Other Medical Supplies

Global Disposable Medical Supplies Market – By Application

Cardiovascular

Cerebrovascular

Ophthalmology

Gynecology

Urology

Orthopedics

Others

Global Disposable Medical Supplies Market – By End-User

Hospitals

Clinics/Physician Offices

Assisted Living Centers & Nursing Homes

Ambulatory Surgery Centers

Research Institutes

Global Disposable Medical Supplies Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020322

Geographic Analysis:

North America held the largest share in terms of revenue in the global disposable medical supplies market due to a growing geriatric population in the region, highly developed healthcare infrastructure, and the rising number of ambulatory facilities in the region. Furthermore, developing countries such as China, India, and Brazil are gaining significance for majority of the disposable medical supplies, as they are focusing towards unmet demand for disposable hospital supplies and devices in these countries.

Competitive Scenario:

The key players operating in the disposable medical supplies market are Abbott Laboratories, Cardinal Health Incorporate, Domtar Corporation, Medtronic plc. 3M Company, Becton, Braun (B.) Terumo Corporation, Smiths Group plc. , Bayer AG, and Melsungen AG.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020322 

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Disposable Medical Supplies industry, although key threats, opportunities and disruptive technologies that could shape the Global Disposable Medical Supplies Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Disposable Medical Supplies Market most.

The data analysis present in the Global Disposable Medical Supplies Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Disposable Medical Supplies Market business.

The 2021 Annual Global Disposable Medical Supplies Market offers:

100+ charts exploring and analysing the Global Disposable Medical Supplies Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Disposable Medical Supplies Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020322 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[jayu123-me]

Medial Polycarbonate Market Research Key Players, Industry Overview and forecasts to 2030

Medical Polycarbonate Market: Introduction

The global Medial Polycarbonate Market Research was valued at ~US$ 1 Bn in 2019 and is anticipated to expand at a CAGR of 3.5% from 2020 to 2030. Polycarbonate’s unique combination of characteristics including its physiological inertness, sterilizing ability, clarity, dimensional stability, high specific stiffness, toughness, and thermal stability helps to maintain its position in the medical sector. North America accounted for major share of the global medical polycarbonate market in 2019. In terms of demand, the U.S. held dominant share of the medical polycarbonate market in North America in 2019. In terms of value, the medical polycarbonate market in the region is expected to expand at a CAGR of 3.5% during the forecast period.

Key Drivers of Medical Polycarbonate Market

Medical polycarbonate is extensively employed in the manufacturing of hemodialysis filter membranes, surgical instrument handles, housings of oxygenators, etc. Its excellent combination of strength, rigidity, toughness, and glass-like clarity makes medical polycarbonate an ideal material for clinical and diagnostic settings, wherein visibility of tissues, blood, and other fluids is required. Furthermore, it is more hydrolytically stable than polyesters, with superior clarity and impact strength. Therefore, medical polycarbonate is used in the production of medical devices. Medical polycarbonate is often used to produce high-pressure syringes, disposable dental instruments, surgical face shields, blood oxygenators, blood collection reservoirs, blood separation devices, surgical devices, kidney dialysis equipment, intravenous components, and centrifuge bowls due to its excellent resistance to acids and oils.

Request PDF Brochure –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12665

Rise in geriatric population and growth in public and private investments in the healthcare sector are expected to drive the demand for medical devices in the near future. Advancements in medical technology is also anticipated to create lucrative opportunities for the medical polycarbonate market in the near future. Population of the elderly is high in Europe and North America. The geriatric population is more susceptible to diseases. This is anticipated to drive the demand for medical devices in Europe and North America in the near future.

North America Dominates Medical Polycarbonate Market

In terms of revenue, North America led the global medical polycarbonate market in 2019. According to the World Health Organization, approximately 17.9 million people died due to cardiovascular diseases across the globe in 2016, representing nearly 31% of all global deaths. About 85% of these deaths were ascribed to heart attack and stroke. According to the American College of Cardiology Foundation, cardiovascular diseases accounted for 840,768 deaths in the U.S. in 2016; of these, 635,260 deaths were owing to cardiac diseases. Medical polycarbonate is extensively used in the production of various medical instruments such as hemodialysis filter membranes, surgical instrument handles, housings of oxygenator devices, needle-free injection systems, perfusion equipment, blood centrifuge bowls, and stopcocks. This is augmenting the medical polycarbonate market.

REQUEST FOR COVID19 IMPACT ANALYSIS –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72423

The medical polycarbonate market is projected to expand at a faster pace in Asia Pacific vis-à-vis that in other regions during the forecast period. According to a report published by the National Center for Biotechnology Information (NCBI) in October 2018, prevalence of chronic kidney disease stands at 10.2% in India. Furthermore, according to an article published in April 2019 by China Daily, a newspaper published in the country, nearly 24.3 million patients were afflicted with diabetic kidney disease in China. Thus, demand for fluid delivery & IV connection components, renal dialysis products, cardiovascular devices, and surgical instruments is high in these countries.

Market Share of Prominent Players

Key players operating in the global medical polycarbonate market are Covestro AG, Mitsubishi Engineering-Plastics Corporations, SABIC, Trinseo S.A., Lotte Chemical Corporation, GOEX Corporation, and Chi Mei Corp. The medical polycarbonate market is highly consolidated. Prominent players are engaged in new product launches to increase their presence in the global market.

Read our Case study at :

https://www.transparencymarketresearch.com/casestudies/chemicals-and-materials-case-study

[rohinic123-blog]

Anticoagulants Market  Estimated to Expand at a Robust CAGR by 2026

Transparency Market Research (TMR) has published a new report titled, “Anticoagulants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global anticoagulants market was valued at US$ 21,759.3 Mn in 2018 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of obesity, increase in hip and knee surgeries, and surge in cases of coagulation disorders are anticipated to boost the growth of the global market from 2018 to 2026.

Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.

Planning To Lay Down Future Strategy? Request Brochure Of Anticoagulants Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60924

Increase in Geriatric Population

Dwindling birth rates have led to an increase in the geriatric population. In Japan, people aged 65 and above currently constitute 23% to 25% of the total population. The percentage is projected to reach 38% by 2050. In North America, the estimates are between 13% and 22% and between 16% and 27% in Europe. Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world. This in turn increases the geriatric population. According to the UN Population Division, the number of people aged 60 and above is anticipated to increase significantly during 2015–2030.

In developed countries, the percentage of people aged 60 and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. On the other hand, in developing countries, the percentage of people aged 60 and above increased from 6% in 1950 to 9% in 2011 and is likely to reach 20% by 2050. Aging makes people prone to fractures and injuries, as their bone density decreases, making them fragile and increasing their susceptibility to falls and arthritis-related fractures. Cardiovascular diseases, kidney disease, osteoporosis, rheumatoid arthritis, and osteoarthritis are common age-related disorders. People aged above 60 are more prone to diseases and disorders. These factors drive demand for anticoagulants products among the geriatric population.

Rise in Cases of Coagulation Disorders

The rise in adoption of Novel Oral Anticoagulants (NOACs) boosts market growth. NOACs target either factor Xa to avoid or to treat thrombosis. These show rapid action and do not require constant monitoring. NOACs also have better efficacy and safety profiles than conventional therapies such as warfarin. Therefore, adoption rate of NOACs has increased in the global anticoagulant market.

Since the introduction of anticoagulants antidotes such as idarucizumab in the market in 2015, acceptance of NOACs has increased, as these eliminate the risk of bleeding. Xarleto and Eliquis are two anticoagulants increasingly preferred by physicians. Xarleto reported a Y-o-Y growth of nearly 10% in 2015, due to increase in volume in some of the key countries such as Japan and Germany. Sales of Eliquis rose by 140.3% due to increase in demand for NOACs globally.

To Obtain All-Inclusive Information On Forecast Analysis Of Anticoagulants Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=60924

Rise in Prevalence of Obesity

Obesity is a key factor for the rise in the number of people suffering from kidney disorders, cardiovascular disorders, and stroke. This is also attributed to changes in lifestyle and lack of physical activity. According to CDC 2015 report, nearly 950,000 people are affected by pulmonary embolism (PE) or deep vein thrombosis (DVT). Moreover, these conditions account for 65,000 to 100,000 deaths in the U.S. each year. Additionally, more than 10% of the geriatric population of the U.S., which accounts for 25 million people, is affected by kidney diseases associated with thrombosis. This is because aging increases the risk of developing renal and cardiovascular diseases, with chances of thromboembolic and hemorrhagic events also rising. This condition is treated using anticoagulants. Increase in the number of people suffering from DVT and surge in number of surgeries are expected to drive the global anticoagulants market.

Increase in Hip and Knee Surgeries

Rise in the number of knee and hip replacement surgeries increases the risk of DVT. For example, surgeries often result in long period of immobility, which increases the chances of developing DVT due to less blood flow in the body. According to CDC 2016 report, over a million people in the U.S. undergo hip and knee replacement surgeries each year. Moreover, the number of surgical procedures has increased among the geriatric population across the globe. Rise in the number of surgeries increases the risk of developing thromboembolic events. This drives demand for treatment using anticoagulants among patients.

Request For Covid19 Impact Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60924

North America to Dominate Global Market

Rise in surgical procedures such as hip and knee replacements is projected to increase the patient pool for treatment with anticoagulants in North America and Europe. According to the Centers for Disease Care and Prevention (2015), around 719,000 knee replacement and 332,000 hip replacement surgeries were performed in the U.S. in 2014. Asia Pacific is expected to be the most lucrative market for anticoagulants from 2018 to 2026. Increase in disposable income, rise in population, and expansion of key players in the region are likely to boost the growth of the anticoagulants market in Asia Pacific.

More Trending Reports by Transparency Market Research –

Infusion Pumps Market –

https://www.prnewswire.com/news-releases/infusion-pumps-market-to-attain-valuation-of-us-10-000-0-million-by-2026--favorable-government-policy-to-boost-market-growth-says-tmr-300791560.html

Clinical Laboratory Services Market -

https://www.biospace.com/article/global-clinical-laboratory-services-market-to-expand-with-advancements-in-the-field-of-clinical-research/

[cmfelatestarticle]

Dialysis Market is predicted to reach USD 1,63,988.18 million by 2030

The Global Dialysis Market held USD 93,428.02 million in 2018 and is predicted to reach USD 1,63,988.18 million by 2030 with a CAGR of 4.8% from 2019-2030      

Dialysis is a process performed in order to remove the waste items, for example, urea and creatinine from the blood that led to improper working of the kidney. This procedure is helpful for patients having chronic renal failures and is majorly used in treating end-stage renal illness as well as during kidney transplantation.

Read Report Overview @

https://www.nextmsc.com/report/dialysis-market

Dialysis purifies the blood, excess fluid & removes toxins, and electrolyte balance is restored in the blood. The increasing utilization of peritoneal dialysis to address the escalating demand for renal replacement therapy. According to the National Kidney Foundation, of the global population around 10% is affected by chronic kidney diseases. This has increased the adoption of dialysis globally, thereby supplementing the dialysis market share in the future.

The increasing prevalence of diabetes that initially affects kidney functioning is likely to positively impact the dialysis market size during the forecast period of 2018 to 2030. Additionally, the R&D investments for innovating dialysis products, shortage of kidneys for transplantation, and technological advancements are key factors to boost the global dialysis market. In addition, rising funding for better dialysis products & services and rising end-stage renal disease (ESRD) patients has supplemented the market growth. However, risks & complications associated with dialysis and product recall may limit the growth of the dialysis market. The untapped markets in the developing countries and increasing demand for home peritoneal dialysis treatment will create new opportunities for market growth in the future.

The dialysis market is segmented on the basis of dialysis type, products & services, end user, and geography. On the basis of dialysis type, the dialysis market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. On the basis of products & services, the market covers equipment, consumables, drugs, and services. The equipment segment is further divided into dialysis machines, water treatment systems, and others. The consumables segment is further distributed as dialyzers, catheters, and others. On the basis of the end user, the dialysis market is classified into in-center dialysis and home dialysis. Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and LAMEA.

North America region holds the highest market share in the dialysis market due to a large number of patient presence in the U.S. and Canada, shortage of kidney donors, high consumer awareness, and technological advancements.

Request to view Sample Report:

https://www.nextmsc.com/Dialysis-Market/request-sample  

Asia-Pacific region is expected to grow with highest CAGR during the forecast period would witness increasing market size owing to the increased purchasing power of the patients, increasing prevalence pool of diabetes and hypertension, and improving compensation scenario and infrastructure.

Comprehensive competitive analysis and profiles of the major market players such as Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others are provided in the dialysis market report.

[martynnx-blog]

U.S. Central Venous Catheter Market 2018–2026: Analysis, Status, Type, Application, Regions, Market Size by Players

Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2610

The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving the central venous catheter market growth. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

Moreover, introduction of innovative products and increasing requirement of long-duration IV therapies such as chemotherapy is expected to boost the market growth. For instance, in May, 2018, Pursuit Vascular, Inc., received the U.S. Food and Drug Administration (FDA) clearance for a broader indication of its ClearGuard HD caps to include reduction in the incidence of central-line associated bloodstream infection (CLABSI) in hemodialysis patients with central venous catheters (CVCs).

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2610

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

[coolluminaryland-blog1]

Anticoagulants Market is Projected to Surpass US$ 40,158.4 Mn by 2026

Transparency Market Research (TMR) has published a new report titled, “Anticoagulants Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global anticoagulants market was valued at US$ 21,759.3 Mn in 2018 and is projected to expand at a CAGR of 8.0% from 2018 to 2026. Rise in prevalence of obesity, increase in hip and knee surgeries, and surge in cases of coagulation disorders are anticipated to boost the growth of the global market from 2018 to 2026.

Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available in the market. These are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction.

Request a PDF Sample of Anticoagulants Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60924

Increase in Geriatric Population

Dwindling birth rates have led to an increase in the geriatric population. In Japan, people aged 65 and above currently constitute 23% to 25% of the total population. The percentage is projected to reach 38% by 2050. In North America, the estimates are between 13% and 22% and between 16% and 27% in Europe. Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world. This in turn increases the geriatric population. According to the UN Population Division, the number of people aged 60 and above is anticipated to increase significantly during 2015–2030. In developed countries, the percentage of people aged 60 and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. On the other hand, in developing countries, the percentage of people aged 60 and above increased from 6% in 1950 to 9% in 2011 and is likely to reach 20% by 2050. Aging makes people prone to fractures and injuries, as their bone density decreases, making them fragile and increasing their susceptibility to falls and arthritis-related fractures. Cardiovascular diseases, kidney disease, osteoporosis, rheumatoid arthritis, and osteoarthritis are common age-related disorders. People aged above 60 are more prone to diseases and disorders. These factors drive demand for anticoagulants products among the geriatric population.

Request Brochure of Anticoagulants Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60924

Rise in Cases of Coagulation Disorders

The rise in adoption of Novel Oral Anticoagulants (NOACs) boosts market growth. NOACs target either factor Xa to avoid or to treat thrombosis. These show rapid action and do not require constant monitoring. NOACs also have better efficacy and safety profiles than conventional therapies such as warfarin. Therefore, adoption rate of NOACs has increased in the global anticoagulant market.

Since the introduction of anticoagulants antidotes such as idarucizumab in the market in 2015, acceptance of NOACs has increased, as these eliminate the risk of bleeding. Xarleto and Eliquis are two anticoagulants increasingly preferred by physicians. Xarleto reported a Y-o-Y growth of nearly 10% in 2015, due to increase in volume in some of the key countries such as Japan and Germany. Sales of Eliquis rose by 140.3% due to increase in demand for NOACs globally.

Rise in Prevalence of Obesity

Obesity is a key factor for the rise in the number of people suffering from kidney disorders, cardiovascular disorders, and stroke. This is also attributed to changes in lifestyle and lack of physical activity. According to CDC 2015 report, nearly 950,000 people are affected by pulmonary embolism (PE) or deep vein thrombosis (DVT). Moreover, these conditions account for 65,000 to 100,000 deaths in the U.S. each year. Additionally, more than 10% of the geriatric population of the U.S., which accounts for 25 million people, is affected by kidney diseases associated with thrombosis. This is because aging increases the risk of developing renal and cardiovascular diseases, with chances of thromboembolic and hemorrhagic events also rising. This condition is treated using anticoagulants. Increase in the number of people suffering from DVT and surge in number of surgeries are expected to drive the global anticoagulants market.

Increase in Hip and Knee Surgeries

Rise in the number of knee and hip replacement surgeries increases the risk of DVT. For example, surgeries often result in long period of immobility, which increases the chances of developing DVT due to less blood flow in the body. According to CDC 2016 report, over a million people in the U.S. undergo hip and knee replacement surgeries each year. Moreover, the number of surgical procedures has increased among the geriatric population across the globe. Rise in the number of surgeries increases the risk of developing thromboembolic events. This drives demand for treatment using anticoagulants among patients.

North America to Dominate Global Market

Rise in surgical procedures such as hip and knee replacements is projected to increase the patient pool for treatment with anticoagulants in North America and Europe. According to the Centers for Disease Care and Prevention (2015), around 719,000 knee replacement and 332,000 hip replacement surgeries were performed in the U.S. in 2014. Asia Pacific is expected to be the most lucrative market for anticoagulants from 2018 to 2026. Increase in disposable income, rise in population, and expansion of key players in the region are likely to boost the growth of the anticoagulants market in Asia Pacific.

[perfectlysizzlingpizza-blog]

Dialysis Centers Market Scope and Opportunities Analysis 2025

Around 10% of the global population is affected by chronic kidney disease (CKD) and over 2 million people suffer from end-stage renal disease (ESRD), which has to be treated by dialysis or kidney transplant. Health care spending on kidney in general and specifically on ESRD is on a rise. In 2014, overall Medicare spending on the treatment of ESRD was over US$ 32 Bn, while the National Health Service (NHS) spends around 3% of its budget on kidney failure services. The burden of kidney diseases is rising in developing countries as well, with nearly half a million patients in China undergoing dialysis (Source: National Kidney Foundation, Center for Medicare and Medicaid Services, NHS).

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/dialysis-centers-market.html

Rise in prevalence of ESRD is driven by increase in prevalence of diabetes and geriatric population. According to the International Diabetes Federation, globally, the number of adults with diabetes (diagnosed or undiagnosed) is projected to increase from 415 million in 2016 to 642 million by 2040, while people aged 60 years and above are expected to account for 17% of the global population by 2030, up from 12% presently (Source: WHO and International Diabetes Federation).

Based on type of services, the global dialysis centers market can be classified into in-center dialysis, in-center nocturnal dialysis, home hemodialysis, peritoneal dialysis, and other services such as disease management and emergency services. Home dialysis offers benefits such as better outcome and higher level of flexibility over in-center dialysis. However, global statistics indicate that over 85% of the patients prefer in-center dialysis even when health care professionals believe that home dialysis could be a better option for ESRD patients. Preference for home dialysis is lower in the U.S., with over 93% of patients choosing in-center hemodialysis.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39254

In terms of region, the global dialysis centers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Presently, majority of the dialysis centers are located in developed economies such as the U.S., Germany, Japan, Italy, and the U.K. More than 2,200 of the 3,600 dialysis centers operated by Fresenius Medical Care are located in the U.S. In India, less than 30% of the ESRD patients undergo dialysis due to factors such as high cost and lack of access to dialysis centers. Moreover, developing economies such as India and China are expected to present significant opportunities in the market due to rise in affordability among the population and government initiatives to improve access to dialysis services. Nephroplus, the largest chain of dialysis centers in India, plans to use the US$ 15 Mn raised through Series-C funding in 2016 to expand from 100 centers to 500 centers in five years.

Key players in the global dialysis centers market are Fresenius Kidney Care, DaVita, Inc., U.S. Renal Care, Inc., Diaverum, NephroCare (part of Fresenius Medical Care), B. Braun Melsungen AG, Yueda Group, NephroPlus, Apex Kidney Care, Deep Chand Dialysis Center, and Kaikoukai Healthcare Group, among others. The market is expected to continue to consolidate, as larger players such as Fresenius and DaVita acquire smaller companies to reduce price competition and increase market share. In May 2018, DaVita acquired ten dialysis centers of Purity Dialysis, a player based in the U.S.

Request Table of Content of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39254

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact US:

Transparency Market Research, 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 Email: sales@transparencymarketresearch.com Website: https://www.transparencymarketresearch.com

[decisionforsight]

Global Ambulatory Services Market

Global Ambulatory Services Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

The global ambulatory services accounted approximate USD 3 trillion in 2020 and it is expected to reach approximate USD 5 trillion by 2030 with a CAGR of 8.10% during forecast period.Ambulatory services refer to medical services performed on outpatient basis, without admission to hospital or other facility. Moreover, these services provided in settings such as dialysis clinics, ambulatory surgical centers, outpatient departments and offices of other health professionals. Additionally, ambulatory services provide services including diagnosis, observation, consultation, treatment, intervention, and rehabilitation services. 

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020160

Market Dynamics and Factors:

Increasing prevalence for outpatient care, as it is cost-effective and does not require hospital stay is the key factor driving the market. Moreover, lowered healthcare expenditure due to high preference for minimally invasive surgeries, rise in aging population and technological advancements will drive the market. Additionally, ease in access, flexible timings and high cost of other alternative treatments are driven the market. Furthermore, as these services are aimed at providing same-day healthcare services are boosting the market growth. Furthermore, recent advancement in ambulatory services such as medical procedures that can be provided without vising the hospital to provide convenient and economic healthcare facilities are anticipated to provide opportunities for market expansion. However, factors such as high cost of treatment and lack of reimbursements are likely to restrain the ambulatory services market.

Market Segmentation:

Global Ambulatory Services Market – By Service Type

Emergency Departments

Surgical Speciality

Primary Care Offices

Medical Specialty

Outpatient Department

Others

Global Ambulatory Services Market – By Application

Opthalmology

Gastroenterology

Orthopedics

Pain Management

Others

Global Ambulatory Services Market – By Geography

North America

U.S.

Canada

Mexico

Europe

U.K.

France

Germany

Italy

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

Rest of Asia Pacific

ROW

Latin America

Middle East

Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020160

Geographic Analysis:

North America is dominating the global ambulatory services market and is anticipated to maintain same trend during the forecast period. Well developed technology, rising healthcare expenditure, presence of leading players in the region are driving the market. According to research report, North America holds approximate 32.5% market share in terms of sales. The region is anticipated to grow with approximate CAGR of 4.8% during forecast period. Europe is the second largest market followed by North America. Increasing geriatric population in the region is driving the market. The region is expected to grow with approximate CAGR of 4.3% during forecast period. The Asia pacific region is anticipated to be the fastest growing ambulatory services market and is expected to grow with approximate CAGR of 5.9% during forecast period. Rising awareness and continuous development such as setting up new institutions and developing infrastructure in the region is driving the market.

Competitive Scenario:

Some of the key players in global ambulatory services market are AmSurg Corp., Symbion Inc., IntergraMed America Inc., Nueterra Capital, Healthway medical corporation ltd., Medical facilities Corp., surgical care affiliates Inc., Aspen Healthcare (private), Conccordia Care Inc., and Crothhall Healthcare Inc.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020160

How will this Market Intelligence Report Benefit You?

The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

Exclusive insight into the key trends affecting the Global Ambulatory Services industry, although key threats, opportunities and disruptive technologies that could shape the Global Ambulatory Services Market supply and demand.

The report tracks the leading market players that will shape and impact the Global Ambulatory Services Market most.

The data analysis present in the Global Ambulatory Services Market report is based on the combination of both primary and secondary resources.

The report helps you to understand the real effects of key market drivers or retainers on Global Ambulatory Services Market business.

The 2021 Annual Global Ambulatory Services Market offers:

100+ charts exploring and analysing the Global Ambulatory Services Market from critical angles including retail forecasts, consumer demand, production and more

15+ profiles of top producing states, with highlights of market conditions and retail trends

Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Ambulatory Services Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020160

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

[martynnx-blog]

Hemodialysis Access Graft Market to Witness Enhanced Growth During 2018-2026

Hemodialysis is one among the three renal replacement therapies used for extracorporeal separation of waste components from the blood in case of kidney failure. Hemodialysis access, also known as vascular access, is a way to access blood for hemodialysis, which can be obtained by three different ways, a fistula, a graft, and a catheter. Hemodialysis access graft are the U-shaped plastic tube used for hemodialysis, which join an artery and veins under the skin of the patient’ arms. Hemodialysis access graft are used in patients with blocked or damaged veins, in which fistula cannot be used. However, hemodialysis access graft do not last as long as fistula, which is expected to be the major factor restraining the hemodialysis access graft market growth. On the other hand, factors that are expected to drive growth include increasing product approvals and rising incidence of chronic kidney disorders. For instance, according to Centers for Disease Control and Prevention (CDC) 2017 factsheet, 30 million people, which comprises 15% of the U.S. adults are estimated to have chronic kidney disease.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1840

Hemodialysis Access Graft Market Dynamics

Novel product launches by market players is a major factor expected to fuel growth the hemodialysis access graft market over the forecast period. For instance, in 2013, CryoLife, Inc., received CE mark for the HeRO Graft, for patients with failing fistulas or blocked veins leading to heart. The company claims HeRO graft as the only fully subcutaneous AV access solution. In 2013, Gore & Associates, launched Gore Acuseal vascular graft for vascular access. The key feature of Gore Acuseal vascular graft is it provides early cannulation i.e. within 24 hours of post-implantation, owing to its trilayer design with low-bleed elastomeric membrane sandwiched between two expanded polytetrafluoroethylene layers. Various companies are adopting trilayer design to sustain in the hemodialysis access graft market. Thus, this can be a growth opportunity for emerging and new entrants in the market.

Increasing incidence of end stage renal disease and other kidney related disorders is a major factor driving growth of the hemodialysis access graft market. According to Centers for Disease Control and Prevention (CDC) factsheet 2017, in 2014, the number of people undergoing treatment for end stage renal diseases were 118,000 in the U.S. and 662,000 were surviving on chronic dialysis or with kidney transplant. According to University of California, 2013, end stage renal disease is increasing by 5% per year in the U.S. In 2013, according to The Renal Association UK Renal Registry, around 57,000 adults in the U.K. were on treatment for kidney failure of which 42% were receiving hemodialysis.

Hemodialysis Access Graft Market – Regional Analysis

Regional segmentation of hemodialysis access graft market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America hemodialysis access graft market is expected to hold a dominant position over the forecast period. This is owing to high prevalence of kidney failure in the region. For instance, according to National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), 2015, in America, around 661,000 Americans suffer from kidney failure, of which 468,000 individuals are on dialysis. However, Asia Pacific hemodialysis access graft market is expected to witness fastest growth, due to large patient pool suffering from diabetes, which increases the chances of renal failure. According to World Health Organization (WHO) 2017 bulletin, South-East Asian population is exhibiting drastic increase in prevalence of diabetes. For instance, the prevalence of diabetes was 46,903,000 in year 2000, which is expected to be 119,541,000 by 2030. This is expected to create a conducive environment for growth of the market in the region.

Hemodialysis Access Graft Market – Competitive Analysis

Key players operating in the global hemodialysis access graft market are W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc. and Getinge Group.

Companies are focusing on acquiring complementary business or products to enter the market. For instance, in 2016, Merit Medical Systems, Inc., a manufacturer and marketer of proprietary disposable medical devices used for interventional and diagnostic procedures, acquired HeRO Graft and its related assets from Cryolife, Inc., for US$ 18.5 million. Furthermore, in 2011, Atrium Medical was acquired by Getinge Group for US$ 680 million. The acquisition of Atrium is a strategic move by Getinge Group to leverage scientific and technological advances of both the companies and company will also get access to vascular grafts of Atrium Medical.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1840